nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzphetamine—POR—Doxorubicin—lung cancer	0.275	0.387	CbGbCtD
Benzphetamine—CYP2B6—Irinotecan—lung cancer	0.0643	0.0903	CbGbCtD
Benzphetamine—CYP2B6—Cisplatin—lung cancer	0.0524	0.0736	CbGbCtD
Benzphetamine—CYP3A4—Topotecan—lung cancer	0.0405	0.0568	CbGbCtD
Benzphetamine—CYP3A4—Gefitinib—lung cancer	0.037	0.052	CbGbCtD
Benzphetamine—CYP3A4—Teniposide—lung cancer	0.0359	0.0504	CbGbCtD
Benzphetamine—CYP2B6—Doxorubicin—lung cancer	0.0351	0.0493	CbGbCtD
Benzphetamine—CYP3A4—Vinorelbine—lung cancer	0.0285	0.04	CbGbCtD
Benzphetamine—CYP3A4—Crizotinib—lung cancer	0.0227	0.0318	CbGbCtD
Benzphetamine—CYP3A4—Erlotinib—lung cancer	0.0219	0.0307	CbGbCtD
Benzphetamine—CYP3A4—Paclitaxel—lung cancer	0.02	0.0281	CbGbCtD
Benzphetamine—CYP3A4—Irinotecan—lung cancer	0.0198	0.0277	CbGbCtD
Benzphetamine—CYP3A4—Vinblastine—lung cancer	0.0176	0.0247	CbGbCtD
Benzphetamine—CYP3A4—Etoposide—lung cancer	0.0158	0.0222	CbGbCtD
Benzphetamine—CYP3A4—Docetaxel—lung cancer	0.0145	0.0203	CbGbCtD
Benzphetamine—CYP3A4—Doxorubicin—lung cancer	0.0108	0.0152	CbGbCtD
Benzphetamine—Cardiomyopathy—Paclitaxel—lung cancer	0.00292	0.0261	CcSEcCtD
Benzphetamine—Trimethaphan—CHRNB4—lung cancer	0.00246	0.228	CrCbGaD
Benzphetamine—Sweating—Teniposide—lung cancer	0.00188	0.0168	CcSEcCtD
Benzphetamine—Trimethaphan—CHRNA3—lung cancer	0.00171	0.158	CrCbGaD
Benzphetamine—Cardiomyopathy—Doxorubicin—lung cancer	0.00155	0.0138	CcSEcCtD
Benzphetamine—Dyspepsia—Crizotinib—lung cancer	0.00149	0.0133	CcSEcCtD
Benzphetamine—Anorexia—Pemetrexed—lung cancer	0.00147	0.0131	CcSEcCtD
Benzphetamine—Decreased appetite—Crizotinib—lung cancer	0.00147	0.0131	CcSEcCtD
Benzphetamine—Anorexia—Gefitinib—lung cancer	0.00146	0.013	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Crizotinib—lung cancer	0.00146	0.013	CcSEcCtD
Benzphetamine—Agitation—Teniposide—lung cancer	0.00141	0.0126	CcSEcCtD
Benzphetamine—Sweating—Topotecan—lung cancer	0.00139	0.0124	CcSEcCtD
Benzphetamine—Dyspepsia—Pemetrexed—lung cancer	0.00136	0.0121	CcSEcCtD
Benzphetamine—Levomethadyl Acetate—CHRNB4—lung cancer	0.00134	0.124	CrCbGaD
Benzphetamine—Decreased appetite—Pemetrexed—lung cancer	0.00134	0.012	CcSEcCtD
Benzphetamine—Decreased appetite—Gefitinib—lung cancer	0.00133	0.0119	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Pemetrexed—lung cancer	0.00133	0.0119	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Gefitinib—lung cancer	0.00132	0.0118	CcSEcCtD
Benzphetamine—POR—respiratory system—lung cancer	0.00125	0.0948	CbGeAlD
Benzphetamine—Urticaria—Pemetrexed—lung cancer	0.00123	0.0109	CcSEcCtD
Benzphetamine—Tachycardia—Teniposide—lung cancer	0.00122	0.0109	CcSEcCtD
Benzphetamine—Urticaria—Gefitinib—lung cancer	0.00122	0.0109	CcSEcCtD
Benzphetamine—Hyperhidrosis—Teniposide—lung cancer	0.00121	0.0108	CcSEcCtD
Benzphetamine—Anorexia—Teniposide—lung cancer	0.00119	0.0106	CcSEcCtD
Benzphetamine—Diarrhoea—Crizotinib—lung cancer	0.00116	0.0103	CcSEcCtD
Benzphetamine—Hypersensitivity—Pemetrexed—lung cancer	0.00114	0.0101	CcSEcCtD
Benzphetamine—Hypersensitivity—Gefitinib—lung cancer	0.00113	0.0101	CcSEcCtD
Benzphetamine—Dizziness—Crizotinib—lung cancer	0.00112	0.00997	CcSEcCtD
Benzphetamine—Decreased appetite—Teniposide—lung cancer	0.00109	0.0097	CcSEcCtD
Benzphetamine—Diarrhoea—Pemetrexed—lung cancer	0.00106	0.00943	CcSEcCtD
Benzphetamine—Diarrhoea—Gefitinib—lung cancer	0.00105	0.00937	CcSEcCtD
Benzphetamine—POR—bronchus—lung cancer	0.00103	0.078	CbGeAlD
Benzphetamine—Dizziness—Pemetrexed—lung cancer	0.00102	0.00911	CcSEcCtD
Benzphetamine—Nausea—Crizotinib—lung cancer	0.001	0.00895	CcSEcCtD
Benzphetamine—Urticaria—Teniposide—lung cancer	0.000993	0.00886	CcSEcCtD
Benzphetamine—Sweating—Irinotecan—lung cancer	0.000983	0.00877	CcSEcCtD
Benzphetamine—Sweating—Gemcitabine—lung cancer	0.000957	0.00854	CcSEcCtD
Benzphetamine—Levomethadyl Acetate—CHRNA3—lung cancer	0.000931	0.0862	CrCbGaD
Benzphetamine—POR—trachea—lung cancer	0.000925	0.07	CbGeAlD
Benzphetamine—Hypersensitivity—Teniposide—lung cancer	0.000921	0.00822	CcSEcCtD
Benzphetamine—Nausea—Pemetrexed—lung cancer	0.000917	0.00818	CcSEcCtD
Benzphetamine—Nausea—Gefitinib—lung cancer	0.000911	0.00813	CcSEcCtD
Benzphetamine—Anorexia—Vinblastine—lung cancer	0.000909	0.00811	CcSEcCtD
Benzphetamine—SLC6A3—respiratory system—lung cancer	0.000902	0.0683	CbGeAlD
Benzphetamine—Hyperhidrosis—Topotecan—lung cancer	0.000896	0.008	CcSEcCtD
Benzphetamine—Anorexia—Topotecan—lung cancer	0.000883	0.00788	CcSEcCtD
Benzphetamine—Anorexia—Erlotinib—lung cancer	0.000874	0.0078	CcSEcCtD
Benzphetamine—POR—cardiac atrium—lung cancer	0.000869	0.0658	CbGeAlD
Benzphetamine—Palpitations—Vinorelbine—lung cancer	0.000858	0.00766	CcSEcCtD
Benzphetamine—Diarrhoea—Teniposide—lung cancer	0.000856	0.00763	CcSEcCtD
Benzphetamine—Insomnia—Erlotinib—lung cancer	0.000829	0.0074	CcSEcCtD
Benzphetamine—Decreased appetite—Vinblastine—lung cancer	0.000829	0.0074	CcSEcCtD
Benzphetamine—Dyspepsia—Topotecan—lung cancer	0.000816	0.00728	CcSEcCtD
Benzphetamine—Dyspepsia—Erlotinib—lung cancer	0.000807	0.0072	CcSEcCtD
Benzphetamine—Decreased appetite—Topotecan—lung cancer	0.000806	0.00719	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Topotecan—lung cancer	0.0008	0.00714	CcSEcCtD
Benzphetamine—Decreased appetite—Erlotinib—lung cancer	0.000797	0.00711	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Erlotinib—lung cancer	0.000792	0.00706	CcSEcCtD
Benzphetamine—Headache—Teniposide—lung cancer	0.000783	0.00699	CcSEcCtD
Benzphetamine—Tachycardia—Vinorelbine—lung cancer	0.000774	0.0069	CcSEcCtD
Benzphetamine—Anorexia—Vinorelbine—lung cancer	0.000756	0.00674	CcSEcCtD
Benzphetamine—Nausea—Teniposide—lung cancer	0.000743	0.00663	CcSEcCtD
Benzphetamine—Urticaria—Topotecan—lung cancer	0.000736	0.00657	CcSEcCtD
Benzphetamine—POR—bone marrow—lung cancer	0.000733	0.0555	CbGeAlD
Benzphetamine—SLC6A2—respiratory system—lung cancer	0.000728	0.0551	CbGeAlD
Benzphetamine—Hypersensitivity—Vinblastine—lung cancer	0.000703	0.00627	CcSEcCtD
Benzphetamine—Decreased appetite—Vinorelbine—lung cancer	0.000689	0.00615	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000684	0.00611	CcSEcCtD
Benzphetamine—Hypersensitivity—Topotecan—lung cancer	0.000683	0.00609	CcSEcCtD
Benzphetamine—Tremor—Cisplatin—lung cancer	0.000682	0.00608	CcSEcCtD
Benzphetamine—POR—lung—lung cancer	0.000665	0.0503	CbGeAlD
Benzphetamine—Diarrhoea—Vinblastine—lung cancer	0.000653	0.00582	CcSEcCtD
Benzphetamine—Diarrhoea—Topotecan—lung cancer	0.000634	0.00566	CcSEcCtD
Benzphetamine—SLC18A2—lung—lung cancer	0.000633	0.048	CbGeAlD
Benzphetamine—Hyperhidrosis—Irinotecan—lung cancer	0.000632	0.00564	CcSEcCtD
Benzphetamine—Dizziness—Vinblastine—lung cancer	0.000631	0.00563	CcSEcCtD
Benzphetamine—Urticaria—Vinorelbine—lung cancer	0.00063	0.00562	CcSEcCtD
Benzphetamine—Diarrhoea—Erlotinib—lung cancer	0.000627	0.0056	CcSEcCtD
Benzphetamine—Anorexia—Irinotecan—lung cancer	0.000623	0.00556	CcSEcCtD
Benzphetamine—Hyperhidrosis—Gemcitabine—lung cancer	0.000616	0.00549	CcSEcCtD
Benzphetamine—Dizziness—Topotecan—lung cancer	0.000613	0.00547	CcSEcCtD
Benzphetamine—Tremor—Paclitaxel—lung cancer	0.000612	0.00546	CcSEcCtD
Benzphetamine—Anorexia—Gemcitabine—lung cancer	0.000607	0.00542	CcSEcCtD
Benzphetamine—Dizziness—Erlotinib—lung cancer	0.000606	0.00541	CcSEcCtD
Benzphetamine—Agitation—Paclitaxel—lung cancer	0.0006	0.00536	CcSEcCtD
Benzphetamine—Headache—Vinblastine—lung cancer	0.000598	0.00533	CcSEcCtD
Benzphetamine—Insomnia—Irinotecan—lung cancer	0.000591	0.00528	CcSEcCtD
Benzphetamine—Hypersensitivity—Vinorelbine—lung cancer	0.000584	0.00521	CcSEcCtD
Benzphetamine—Headache—Topotecan—lung cancer	0.000581	0.00518	CcSEcCtD
Benzphetamine—Tachycardia—Cisplatin—lung cancer	0.000579	0.00517	CcSEcCtD
Benzphetamine—Palpitations—Paclitaxel—lung cancer	0.000577	0.00515	CcSEcCtD
Benzphetamine—Insomnia—Gemcitabine—lung cancer	0.000576	0.00514	CcSEcCtD
Benzphetamine—Dyspepsia—Irinotecan—lung cancer	0.000576	0.00514	CcSEcCtD
Benzphetamine—Headache—Erlotinib—lung cancer	0.000574	0.00513	CcSEcCtD
Benzphetamine—Hyperhidrosis—Cisplatin—lung cancer	0.000574	0.00512	CcSEcCtD
Benzphetamine—Decreased appetite—Irinotecan—lung cancer	0.000568	0.00507	CcSEcCtD
Benzphetamine—Nausea—Vinblastine—lung cancer	0.000567	0.00506	CcSEcCtD
Benzphetamine—Anorexia—Cisplatin—lung cancer	0.000566	0.00505	CcSEcCtD
Benzphetamine—ADRA1A—epithelium—lung cancer	0.000566	0.0428	CbGeAlD
Benzphetamine—Gastrointestinal disorder—Irinotecan—lung cancer	0.000565	0.00504	CcSEcCtD
Benzphetamine—Decreased appetite—Gemcitabine—lung cancer	0.000554	0.00494	CcSEcCtD
Benzphetamine—Nausea—Topotecan—lung cancer	0.000551	0.00491	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Gemcitabine—lung cancer	0.00055	0.00491	CcSEcCtD
Benzphetamine—Nausea—Erlotinib—lung cancer	0.000545	0.00486	CcSEcCtD
Benzphetamine—Diarrhoea—Vinorelbine—lung cancer	0.000542	0.00484	CcSEcCtD
Benzphetamine—CYP2B6—respiratory system—lung cancer	0.000536	0.0406	CbGeAlD
Benzphetamine—Tachycardia—Etoposide—lung cancer	0.000531	0.00474	CcSEcCtD
Benzphetamine—Hyperhidrosis—Etoposide—lung cancer	0.000526	0.00469	CcSEcCtD
Benzphetamine—Dizziness—Vinorelbine—lung cancer	0.000524	0.00468	CcSEcCtD
Benzphetamine—Tachycardia—Paclitaxel—lung cancer	0.00052	0.00464	CcSEcCtD
Benzphetamine—Anorexia—Etoposide—lung cancer	0.000518	0.00463	CcSEcCtD
Benzphetamine—Decreased appetite—Cisplatin—lung cancer	0.000516	0.00461	CcSEcCtD
Benzphetamine—Hyperhidrosis—Paclitaxel—lung cancer	0.000516	0.0046	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Cisplatin—lung cancer	0.000513	0.00457	CcSEcCtD
Benzphetamine—Anorexia—Paclitaxel—lung cancer	0.000508	0.00454	CcSEcCtD
Benzphetamine—Headache—Vinorelbine—lung cancer	0.000497	0.00443	CcSEcCtD
Benzphetamine—Sweating—Methotrexate—lung cancer	0.00049	0.00437	CcSEcCtD
Benzphetamine—Palpitations—Docetaxel—lung cancer	0.000489	0.00437	CcSEcCtD
Benzphetamine—Insomnia—Paclitaxel—lung cancer	0.000482	0.0043	CcSEcCtD
Benzphetamine—Hypersensitivity—Irinotecan—lung cancer	0.000482	0.0043	CcSEcCtD
Benzphetamine—SLC6A3—lung—lung cancer	0.000479	0.0363	CbGeAlD
Benzphetamine—Decreased appetite—Etoposide—lung cancer	0.000473	0.00422	CcSEcCtD
Benzphetamine—Nausea—Vinorelbine—lung cancer	0.000471	0.0042	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Etoposide—lung cancer	0.00047	0.00419	CcSEcCtD
Benzphetamine—Dyspepsia—Paclitaxel—lung cancer	0.000469	0.00419	CcSEcCtD
Benzphetamine—Decreased appetite—Paclitaxel—lung cancer	0.000464	0.00414	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Paclitaxel—lung cancer	0.00046	0.00411	CcSEcCtD
Benzphetamine—POR—lymph node—lung cancer	0.000454	0.0344	CbGeAlD
Benzphetamine—Diarrhoea—Irinotecan—lung cancer	0.000447	0.00399	CcSEcCtD
Benzphetamine—CYP2B6—bronchus—lung cancer	0.000441	0.0334	CbGeAlD
Benzphetamine—Tachycardia—Docetaxel—lung cancer	0.000441	0.00394	CcSEcCtD
Benzphetamine—Hypersensitivity—Cisplatin—lung cancer	0.000437	0.0039	CcSEcCtD
Benzphetamine—Diarrhoea—Gemcitabine—lung cancer	0.000436	0.00389	CcSEcCtD
Benzphetamine—SLC18A2—lymph node—lung cancer	0.000433	0.0328	CbGeAlD
Benzphetamine—Dizziness—Irinotecan—lung cancer	0.000432	0.00386	CcSEcCtD
Benzphetamine—Urticaria—Etoposide—lung cancer	0.000432	0.00386	CcSEcCtD
Benzphetamine—Anorexia—Docetaxel—lung cancer	0.000431	0.00384	CcSEcCtD
Benzphetamine—Sweating—Doxorubicin—lung cancer	0.000424	0.00378	CcSEcCtD
Benzphetamine—Urticaria—Paclitaxel—lung cancer	0.000424	0.00378	CcSEcCtD
Benzphetamine—ADRA2A—bronchus—lung cancer	0.000423	0.0321	CbGeAlD
Benzphetamine—Headache—Irinotecan—lung cancer	0.00041	0.00366	CcSEcCtD
Benzphetamine—Insomnia—Docetaxel—lung cancer	0.000409	0.00365	CcSEcCtD
Benzphetamine—Toremifene—CYP1A1—lung cancer	0.000408	0.0378	CrCbGaD
Benzphetamine—Diarrhoea—Cisplatin—lung cancer	0.000406	0.00362	CcSEcCtD
Benzphetamine—Hypersensitivity—Etoposide—lung cancer	0.000401	0.00358	CcSEcCtD
Benzphetamine—Headache—Gemcitabine—lung cancer	0.000399	0.00356	CcSEcCtD
Benzphetamine—Dyspepsia—Docetaxel—lung cancer	0.000398	0.00355	CcSEcCtD
Benzphetamine—Decreased appetite—Docetaxel—lung cancer	0.000393	0.00351	CcSEcCtD
Benzphetamine—Hypersensitivity—Paclitaxel—lung cancer	0.000393	0.00351	CcSEcCtD
Benzphetamine—Selegiline—CYP2A6—lung cancer	0.00039	0.0361	CrCbGaD
Benzphetamine—Gastrointestinal disorder—Docetaxel—lung cancer	0.00039	0.00348	CcSEcCtD
Benzphetamine—Nausea—Irinotecan—lung cancer	0.000388	0.00347	CcSEcCtD
Benzphetamine—SLC6A2—lung—lung cancer	0.000387	0.0293	CbGeAlD
Benzphetamine—ADRA2A—trachea—lung cancer	0.00038	0.0288	CbGeAlD
Benzphetamine—Nausea—Gemcitabine—lung cancer	0.000378	0.00338	CcSEcCtD
Benzphetamine—Diarrhoea—Etoposide—lung cancer	0.000372	0.00332	CcSEcCtD
Benzphetamine—Diarrhoea—Paclitaxel—lung cancer	0.000365	0.00326	CcSEcCtD
Benzphetamine—Dizziness—Etoposide—lung cancer	0.00036	0.00321	CcSEcCtD
Benzphetamine—ADRA2A—cardiac atrium—lung cancer	0.000357	0.027	CbGeAlD
Benzphetamine—Dizziness—Paclitaxel—lung cancer	0.000353	0.00315	CcSEcCtD
Benzphetamine—Nausea—Cisplatin—lung cancer	0.000353	0.00315	CcSEcCtD
Benzphetamine—Headache—Etoposide—lung cancer	0.000341	0.00304	CcSEcCtD
Benzphetamine—Headache—Paclitaxel—lung cancer	0.000334	0.00298	CcSEcCtD
Benzphetamine—Hypersensitivity—Docetaxel—lung cancer	0.000333	0.00297	CcSEcCtD
Benzphetamine—Amphetamine—CYP2A6—lung cancer	0.000324	0.03	CrCbGaD
Benzphetamine—Nausea—Etoposide—lung cancer	0.000323	0.00288	CcSEcCtD
Benzphetamine—Agitation—Doxorubicin—lung cancer	0.000318	0.00283	CcSEcCtD
Benzphetamine—Nausea—Paclitaxel—lung cancer	0.000317	0.00283	CcSEcCtD
Benzphetamine—Hyperhidrosis—Methotrexate—lung cancer	0.000315	0.00281	CcSEcCtD
Benzphetamine—Anorexia—Methotrexate—lung cancer	0.000311	0.00277	CcSEcCtD
Benzphetamine—Diarrhoea—Docetaxel—lung cancer	0.000309	0.00276	CcSEcCtD
Benzphetamine—Palpitations—Doxorubicin—lung cancer	0.000305	0.00273	CcSEcCtD
Benzphetamine—Dizziness—Docetaxel—lung cancer	0.000299	0.00267	CcSEcCtD
Benzphetamine—Insomnia—Methotrexate—lung cancer	0.000295	0.00263	CcSEcCtD
Benzphetamine—Oxaprozin—PTGS2—lung cancer	0.000291	0.0269	CrCbGaD
Benzphetamine—Dyspepsia—Methotrexate—lung cancer	0.000287	0.00256	CcSEcCtD
Benzphetamine—CYP2B6—lung—lung cancer	0.000285	0.0216	CbGeAlD
Benzphetamine—Decreased appetite—Methotrexate—lung cancer	0.000283	0.00253	CcSEcCtD
Benzphetamine—Headache—Docetaxel—lung cancer	0.000283	0.00253	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Methotrexate—lung cancer	0.000281	0.00251	CcSEcCtD
Benzphetamine—Selegiline—CYP2E1—lung cancer	0.000277	0.0257	CrCbGaD
Benzphetamine—Tachycardia—Doxorubicin—lung cancer	0.000275	0.00246	CcSEcCtD
Benzphetamine—ADRA2A—lung—lung cancer	0.000273	0.0207	CbGeAlD
Benzphetamine—Hyperhidrosis—Doxorubicin—lung cancer	0.000273	0.00243	CcSEcCtD
Benzphetamine—Anorexia—Doxorubicin—lung cancer	0.000269	0.0024	CcSEcCtD
Benzphetamine—Nausea—Docetaxel—lung cancer	0.000268	0.0024	CcSEcCtD
Benzphetamine—SLC6A2—lymph node—lung cancer	0.000264	0.02	CbGeAlD
Benzphetamine—Urticaria—Methotrexate—lung cancer	0.000259	0.00231	CcSEcCtD
Benzphetamine—Insomnia—Doxorubicin—lung cancer	0.000255	0.00228	CcSEcCtD
Benzphetamine—Dyspepsia—Doxorubicin—lung cancer	0.000248	0.00222	CcSEcCtD
Benzphetamine—Decreased appetite—Doxorubicin—lung cancer	0.000245	0.00219	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000244	0.00217	CcSEcCtD
Benzphetamine—Hypersensitivity—Methotrexate—lung cancer	0.00024	0.00214	CcSEcCtD
Benzphetamine—Tamoxifen—CYP2A6—lung cancer	0.000233	0.0215	CrCbGaD
Benzphetamine—Urticaria—Doxorubicin—lung cancer	0.000224	0.002	CcSEcCtD
Benzphetamine—Diarrhoea—Methotrexate—lung cancer	0.000223	0.00199	CcSEcCtD
Benzphetamine—Toremifene—ABCB1—lung cancer	0.000217	0.0201	CrCbGaD
Benzphetamine—Dizziness—Methotrexate—lung cancer	0.000215	0.00192	CcSEcCtD
Benzphetamine—Tamoxifen—ABCG2—lung cancer	0.000208	0.0193	CrCbGaD
Benzphetamine—Hypersensitivity—Doxorubicin—lung cancer	0.000208	0.00185	CcSEcCtD
Benzphetamine—Headache—Methotrexate—lung cancer	0.000204	0.00182	CcSEcCtD
Benzphetamine—Nausea—Methotrexate—lung cancer	0.000194	0.00173	CcSEcCtD
Benzphetamine—Diarrhoea—Doxorubicin—lung cancer	0.000193	0.00172	CcSEcCtD
Benzphetamine—Phenylbutazone—PTGS2—lung cancer	0.000192	0.0178	CrCbGaD
Benzphetamine—ADRA2A—lymph node—lung cancer	0.000187	0.0141	CbGeAlD
Benzphetamine—Dizziness—Doxorubicin—lung cancer	0.000187	0.00166	CcSEcCtD
Benzphetamine—Phenprocoumon—ALB—lung cancer	0.000185	0.0171	CrCbGaD
Benzphetamine—Headache—Doxorubicin—lung cancer	0.000177	0.00158	CcSEcCtD
Benzphetamine—Nausea—Doxorubicin—lung cancer	0.000168	0.0015	CcSEcCtD
Benzphetamine—Tamoxifen—CYP2E1—lung cancer	0.000165	0.0153	CrCbGaD
Benzphetamine—Tamoxifen—CYP1A1—lung cancer	0.000163	0.0151	CrCbGaD
Benzphetamine—Orphenadrine—CYP2E1—lung cancer	0.00016	0.0149	CrCbGaD
Benzphetamine—Propafenone—ABCB1—lung cancer	0.000153	0.0141	CrCbGaD
Benzphetamine—Selegiline—ABCB1—lung cancer	0.000145	0.0135	CrCbGaD
Benzphetamine—Bepridil—ABCB1—lung cancer	0.000136	0.0126	CrCbGaD
Benzphetamine—Fentanyl—ABCB1—lung cancer	0.000125	0.0116	CrCbGaD
Benzphetamine—Phenytoin—ALB—lung cancer	0.000119	0.011	CrCbGaD
Benzphetamine—Phenytoin—ABCB1—lung cancer	0.000114	0.0105	CrCbGaD
Benzphetamine—Trimipramine—ABCB1—lung cancer	9.06e-05	0.00839	CrCbGaD
Benzphetamine—Promethazine—ABCB1—lung cancer	8.72e-05	0.00807	CrCbGaD
Benzphetamine—Tamoxifen—ABCB1—lung cancer	8.66e-05	0.00802	CrCbGaD
Benzphetamine—Methadone—ABCB1—lung cancer	8.59e-05	0.00795	CrCbGaD
Benzphetamine—CYP2B6—Metabolism—NQO1—lung cancer	2.46e-05	0.000162	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—FGF9—lung cancer	2.46e-05	0.000162	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ANXA1—lung cancer	2.43e-05	0.00016	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PGAM1—lung cancer	2.4e-05	0.000158	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—POMC—lung cancer	2.39e-05	0.000157	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—STK11—lung cancer	2.37e-05	0.000156	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—FLT1—lung cancer	2.35e-05	0.000155	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—JUNB—lung cancer	2.35e-05	0.000155	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—PIK3CG—lung cancer	2.33e-05	0.000154	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—EP300—lung cancer	2.33e-05	0.000154	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—APP—lung cancer	2.3e-05	0.000152	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NOTCH3—lung cancer	2.3e-05	0.000152	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CYP2A7—lung cancer	2.29e-05	0.000151	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—FGF9—lung cancer	2.28e-05	0.000151	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—PIK3CG—lung cancer	2.28e-05	0.00015	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—SRC—lung cancer	2.26e-05	0.000149	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—SDC4—lung cancer	2.24e-05	0.000148	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—STK11—lung cancer	2.22e-05	0.000146	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—POMC—lung cancer	2.22e-05	0.000146	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—VEGFA—lung cancer	2.2e-05	0.000145	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—PIK3CD—lung cancer	2.2e-05	0.000145	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—GSTP1—lung cancer	2.19e-05	0.000144	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—JUNB—lung cancer	2.18e-05	0.000144	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—NRAS—lung cancer	2.18e-05	0.000144	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—POMC—lung cancer	2.17e-05	0.000143	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CAT—lung cancer	2.13e-05	0.000141	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—STK11—lung cancer	2.13e-05	0.000141	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PIK3CG—lung cancer	2.12e-05	0.00014	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—IL6R—lung cancer	2.11e-05	0.000139	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—MAPK3—lung cancer	2.09e-05	0.000138	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—ABCB1—lung cancer	2.07e-05	0.000137	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—FOXO3—lung cancer	2.06e-05	0.000136	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GSTP1—lung cancer	2.05e-05	0.000135	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—PIK3CD—lung cancer	2.05e-05	0.000135	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GSTA3—lung cancer	2.04e-05	0.000135	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—RRM1—lung cancer	2.04e-05	0.000135	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—TYMS—lung cancer	2.04e-05	0.000134	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—MAP2K1—lung cancer	2.01e-05	0.000133	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—POMC—lung cancer	2.01e-05	0.000133	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—GSTM1—lung cancer	2.01e-05	0.000133	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—PIK3CD—lung cancer	2e-05	0.000132	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CAT—lung cancer	2e-05	0.000132	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—STK11—lung cancer	1.98e-05	0.000131	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—IL6R—lung cancer	1.96e-05	0.00013	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ABCB1—lung cancer	1.94e-05	0.000128	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—AVP—lung cancer	1.93e-05	0.000127	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—PIK3CB—lung cancer	1.92e-05	0.000127	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—B4GALT5—lung cancer	1.92e-05	0.000127	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—FOXO3—lung cancer	1.91e-05	0.000126	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—TYMS—lung cancer	1.91e-05	0.000126	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CYP1A1—lung cancer	1.91e-05	0.000126	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—ERCC2—lung cancer	1.89e-05	0.000125	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GSTM1—lung cancer	1.89e-05	0.000124	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—KRAS—lung cancer	1.87e-05	0.000124	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—MAP2K1—lung cancer	1.87e-05	0.000124	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GSTA4—lung cancer	1.87e-05	0.000123	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PIK3CD—lung cancer	1.86e-05	0.000123	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IGF1R—lung cancer	1.85e-05	0.000122	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—CXCL8—lung cancer	1.85e-05	0.000122	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—HES1—lung cancer	1.82e-05	0.00012	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GSTA2—lung cancer	1.82e-05	0.00012	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—AVP—lung cancer	1.79e-05	0.000118	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CYP1A1—lung cancer	1.79e-05	0.000118	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—RAF1—lung cancer	1.79e-05	0.000118	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—PIK3CB—lung cancer	1.79e-05	0.000118	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ERCC2—lung cancer	1.77e-05	0.000117	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—IL2—lung cancer	1.76e-05	0.000116	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GSTA1—lung cancer	1.76e-05	0.000116	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—PIK3CB—lung cancer	1.74e-05	0.000115	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ABCC3—lung cancer	1.74e-05	0.000115	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IGF1R—lung cancer	1.72e-05	0.000114	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—PIK3CA—lung cancer	1.72e-05	0.000114	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—CXCL8—lung cancer	1.72e-05	0.000113	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HES1—lung cancer	1.69e-05	0.000112	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—AKR1C1—lung cancer	1.68e-05	0.000111	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—CXCL8—lung cancer	1.68e-05	0.000111	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—TP53—lung cancer	1.67e-05	0.00011	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ERBB3—lung cancer	1.67e-05	0.00011	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—RAF1—lung cancer	1.66e-05	0.00011	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—IL2—lung cancer	1.64e-05	0.000108	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—APOA1—lung cancer	1.64e-05	0.000108	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—UGT1A1—lung cancer	1.63e-05	0.000108	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PIK3CB—lung cancer	1.62e-05	0.000107	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—IL2—lung cancer	1.6e-05	0.000106	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TERT—lung cancer	1.6e-05	0.000105	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—HRAS—lung cancer	1.59e-05	0.000105	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GNG11—lung cancer	1.57e-05	0.000104	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CXCL8—lung cancer	1.56e-05	0.000103	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—FGFR1—lung cancer	1.55e-05	0.000102	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ERBB3—lung cancer	1.55e-05	0.000102	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—APOA1—lung cancer	1.53e-05	0.000101	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—HIF1A—lung cancer	1.53e-05	0.000101	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ALDOA—lung cancer	1.5e-05	9.89e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PIK3CG—lung cancer	1.49e-05	9.86e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—IL2—lung cancer	1.49e-05	9.82e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TERT—lung cancer	1.48e-05	9.79e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—APOA1—lung cancer	1.47e-05	9.72e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—KDR—lung cancer	1.46e-05	9.63e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—NCOA3—lung cancer	1.46e-05	9.6e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—FGFR1—lung cancer	1.44e-05	9.5e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—POMC—lung cancer	1.42e-05	9.39e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HIF1A—lung cancer	1.42e-05	9.36e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ADCY1—lung cancer	1.42e-05	9.34e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ABCG2—lung cancer	1.42e-05	9.34e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—AKT1—lung cancer	1.41e-05	9.28e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PIK3CG—lung cancer	1.4e-05	9.24e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—HPGDS—lung cancer	1.39e-05	9.16e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ENO2—lung cancer	1.39e-05	9.16e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CREBBP—lung cancer	1.39e-05	9.14e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.38e-05	9.1e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—APOA1—lung cancer	1.37e-05	9.03e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—KDR—lung cancer	1.36e-05	8.95e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GSTT1—lung cancer	1.35e-05	8.88e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—APC—lung cancer	1.35e-05	8.87e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—KIT—lung cancer	1.35e-05	8.87e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PIK3CG—lung cancer	1.35e-05	8.87e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—NRAS—lung cancer	1.35e-05	8.87e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—POMC—lung cancer	1.33e-05	8.8e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CYP2A6—lung cancer	1.33e-05	8.78e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GCLC—lung cancer	1.33e-05	8.78e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—EGF—lung cancer	1.33e-05	8.77e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PIK3CD—lung cancer	1.31e-05	8.67e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CREBBP—lung cancer	1.3e-05	8.57e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—ALB—lung cancer	1.3e-05	8.56e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—MAPK3—lung cancer	1.29e-05	8.5e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—POMC—lung cancer	1.28e-05	8.45e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—BRAF—lung cancer	1.26e-05	8.34e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ENO1—lung cancer	1.26e-05	8.32e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PIK3CG—lung cancer	1.25e-05	8.24e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—KIT—lung cancer	1.25e-05	8.24e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—APC—lung cancer	1.25e-05	8.24e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—NRAS—lung cancer	1.25e-05	8.24e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IL6R—lung cancer	1.25e-05	8.24e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CREBBP—lung cancer	1.25e-05	8.23e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—EGF—lung cancer	1.24e-05	8.15e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PIK3CD—lung cancer	1.23e-05	8.13e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—EGFR—lung cancer	1.23e-05	8.08e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ALB—lung cancer	1.22e-05	8.02e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—MAPK3—lung cancer	1.2e-05	7.9e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MAP2K1—lung cancer	1.19e-05	7.85e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—POMC—lung cancer	1.19e-05	7.85e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PIK3CD—lung cancer	1.18e-05	7.8e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—BRAF—lung cancer	1.17e-05	7.75e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—PIK3CA—lung cancer	1.17e-05	7.73e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IL6R—lung cancer	1.16e-05	7.66e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CREBBP—lung cancer	1.16e-05	7.64e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—KRAS—lung cancer	1.16e-05	7.64e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PIK3CB—lung cancer	1.15e-05	7.56e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—EGFR—lung cancer	1.14e-05	7.51e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PTGS2—lung cancer	1.13e-05	7.49e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CYP2E1—lung cancer	1.13e-05	7.46e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—NQO1—lung cancer	1.12e-05	7.38e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MAP2K1—lung cancer	1.11e-05	7.3e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PIK3CD—lung cancer	1.1e-05	7.25e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—PIK3CA—lung cancer	1.09e-05	7.18e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—KRAS—lung cancer	1.08e-05	7.1e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PIK3CB—lung cancer	1.07e-05	7.08e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PTGS2—lung cancer	1.06e-05	7.02e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—PIK3CA—lung cancer	1.06e-05	7.02e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MDM2—lung cancer	1.06e-05	6.99e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—RAF1—lung cancer	1.06e-05	6.96e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ERBB2—lung cancer	1.04e-05	6.89e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MTOR—lung cancer	1.03e-05	6.8e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PIK3CB—lung cancer	1.03e-05	6.8e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—STK11—lung cancer	1.01e-05	6.65e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CXCL8—lung cancer	9.9e-06	6.53e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PTEN—lung cancer	9.9e-06	6.53e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PIK3CA—lung cancer	9.88e-06	6.52e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MDM2—lung cancer	9.84e-06	6.49e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—HRAS—lung cancer	9.84e-06	6.49e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—RAF1—lung cancer	9.81e-06	6.47e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ERBB2—lung cancer	9.7e-06	6.4e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MTOR—lung cancer	9.58e-06	6.32e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PIK3CB—lung cancer	9.58e-06	6.32e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—AKT1—lung cancer	9.57e-06	6.31e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CASP3—lung cancer	9.48e-06	6.25e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IL2—lung cancer	9.47e-06	6.24e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—EP300—lung cancer	9.44e-06	6.23e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—IL6—lung cancer	9.42e-06	6.21e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GSTP1—lung cancer	9.33e-06	6.16e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PTEN—lung cancer	9.28e-06	6.12e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CCND1—lung cancer	9.23e-06	6.09e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—JUN—lung cancer	9.21e-06	6.07e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CXCL8—lung cancer	9.2e-06	6.07e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—HRAS—lung cancer	9.14e-06	6.03e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CAT—lung cancer	9.08e-06	5.99e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MMP9—lung cancer	8.96e-06	5.91e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CDKN1A—lung cancer	8.93e-06	5.89e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PTEN—lung cancer	8.91e-06	5.88e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—AKT1—lung cancer	8.89e-06	5.86e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—EP300—lung cancer	8.85e-06	5.84e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ABCB1—lung cancer	8.83e-06	5.83e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CASP3—lung cancer	8.81e-06	5.81e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IL2—lung cancer	8.79e-06	5.8e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—IL6—lung cancer	8.75e-06	5.77e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—AKT1—lung cancer	8.69e-06	5.73e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—TYMS—lung cancer	8.68e-06	5.72e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GSTM1—lung cancer	8.58e-06	5.66e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CCND1—lung cancer	8.57e-06	5.66e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—JUN—lung cancer	8.56e-06	5.64e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—EP300—lung cancer	8.49e-06	5.6e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MMP9—lung cancer	8.32e-06	5.49e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CDKN1A—lung cancer	8.29e-06	5.47e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PTEN—lung cancer	8.28e-06	5.46e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—SRC—lung cancer	8.26e-06	5.45e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CYP1A1—lung cancer	8.13e-06	5.36e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—AKT1—lung cancer	8.07e-06	5.33e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ERCC2—lung cancer	8.06e-06	5.32e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—VEGFA—lung cancer	8.04e-06	5.31e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—STAT3—lung cancer	7.97e-06	5.25e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NRAS—lung cancer	7.95e-06	5.24e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—EP300—lung cancer	7.89e-06	5.21e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—SRC—lung cancer	7.67e-06	5.06e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MAPK3—lung cancer	7.61e-06	5.02e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—VEGFA—lung cancer	7.47e-06	4.93e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MYC—lung cancer	7.4e-06	4.88e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—STAT3—lung cancer	7.4e-06	4.88e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NRAS—lung cancer	7.38e-06	4.87e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—EGFR—lung cancer	7.24e-06	4.78e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MAPK3—lung cancer	7.07e-06	4.66e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PIK3CA—lung cancer	6.98e-06	4.61e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—APOA1—lung cancer	6.97e-06	4.6e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MYC—lung cancer	6.88e-06	4.54e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—KRAS—lung cancer	6.84e-06	4.51e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—EGFR—lung cancer	6.73e-06	4.44e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PIK3CA—lung cancer	6.55e-06	4.32e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PIK3CG—lung cancer	6.37e-06	4.2e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—KRAS—lung cancer	6.35e-06	4.19e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PIK3CA—lung cancer	6.28e-06	4.14e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TP53—lung cancer	6.08e-06	4.01e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—POMC—lung cancer	6.06e-06	4e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CREBBP—lung cancer	5.9e-06	3.89e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PIK3CA—lung cancer	5.84e-06	3.85e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—HRAS—lung cancer	5.81e-06	3.83e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—AKT1—lung cancer	5.7e-06	3.76e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TP53—lung cancer	5.65e-06	3.73e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PIK3CD—lung cancer	5.6e-06	3.69e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IL6—lung cancer	5.56e-06	3.67e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ALB—lung cancer	5.53e-06	3.65e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HRAS—lung cancer	5.4e-06	3.56e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—AKT1—lung cancer	5.35e-06	3.53e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IL6—lung cancer	5.17e-06	3.41e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—AKT1—lung cancer	5.13e-06	3.39e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PIK3CB—lung cancer	4.88e-06	3.22e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PTGS2—lung cancer	4.83e-06	3.19e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—AKT1—lung cancer	4.77e-06	3.15e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PTEN—lung cancer	4.22e-06	2.78e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—EP300—lung cancer	4.02e-06	2.65e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PIK3CA—lung cancer	2.97e-06	1.96e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—AKT1—lung cancer	2.43e-06	1.6e-05	CbGpPWpGaD
